Solifenacin in Multiple Sclerosis Patients with Overactive Bladder: A Prospective Study

Objective. To assess the efficacy and the effect on Qol of solifenacin for the treatment of OAB in MS patients. Patients and Methods. Thirty MS patients suffering from OAB were treated with solifenacin 5/10 mg for 8 weeks. The first 4 weeks patients received solifenacin 5 mg. At week 4 patients coul...

Full description

Saved in:
Bibliographic Details
Main Authors: Farida van Rey, John Heesakkers
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Advances in Urology
Online Access:http://dx.doi.org/10.1155/2011/834753
Tags: Add Tag
No Tags, Be the first to tag this record!